Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Graft vs Host Disease × sargramostim × 1 year × Clear all

Sponsor

Conditions

Neuroblastoma 11 Ganglioneuroblastoma 4 Triple Negative Breast Neoplasms 3 Melanoma 3 Lung Neoplasms 3 Carcinoma, Non-Small-Cell Lung 2 Wilms Tumor 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Transplant-Related Hematologic Malignancy 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Alveolar Soft Part 1 Recurrence 1 Pathologic Complete Response 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Mesothelioma, Malignant 1 Mesothelioma 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma 1 Locally Advanced Pancreatic Adenocarcinoma 1 Leukemia, Plasma Cell 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Hodgkin Disease 1 Gliosarcoma 1 Glioblastoma 1 Endometrial Neoplasms 1 Carcinosarcoma 1

Interventions

Cyclophosphamide 14 Mycophenolic Acid 10 Tacrolimus 9 fludarabine 7 ruxolitinib 6 Whole-Body Irradiation 5 Melphalan 5 Busulfan 5 fludarabine phosphate 4 Sirolimus 4 Methotrexate 4 Hematopoietic Stem Cell Transplantation 3 ibrutinib 2 Thiotepa 2 Stem Cell Transplantation 2 Specimen Handling 2 Radiotherapy 2 Cyclosporine 2 Biopsy 2 Abatacept 2 vedolizumab 1 tildrakizumab 1 itacitinib 1 interferon gamma-1b 1 blinatumomab 1 belumosudil 1 axatilimab 1 Vorinostat 1 Tomography, Optical Coherence 1 Therapeutics 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡